Kim Narunsky
Cape Town, WC, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 16, 2026
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions.
Journal: Science translational medicine
Published: January 07, 2026
PET/CT guided tuberculosis treatment shortening: a randomized trial.
Journal: medRxiv : the preprint server for health sciences
Published: January 13, 2025
Population pharmacokinetics and exposure-response relationship of the antituberculosis drug BTZ-043.
Population pharmacokinetics and exposure-response relationship of the antituberculosis drug BTZ-043.
Journal: The Journal of antimicrobial chemotherapy
Published: October 04, 2024
Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial.
Journal: The Lancet. Infectious diseases
Published: April 26, 2024
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043-02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial.
Journal: The Lancet. Microbe
Published: October 26, 2023
Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: September 28, 2023
Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832.
Journal: Antimicrobial agents and chemotherapy
Published: May 23, 2023
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results.
Journal: American journal of respiratory and critical care medicine
Published: December 01, 2022
High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis.
Journal: The Pediatric infectious disease journal
Published: March 03, 2022
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
Journal: The New England journal of medicine
Published: May 05, 2021
Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 26, 2020
Last Updated: 09/26/2026